Crystal and molecular structures of 4-aryl-1,4-dihydropyrimidines: Novel calcium channel antagonists

Zeitschrift fur Kristallographie

Volumn 218, Issue 1, 2003, Pages 46-55

  Mohan, K Chandra ^a   Ravikumar, K ^a   Shetty, M M ^a   Velmurugan, D ^b  

^a INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

^b UNIVERSITY OF MADRAS   (India)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDRO 6 METHYL 5 N METHYL CARBAMOYL 4 (2',4' DICHLOROPHENYL) 2(3H) PYRIMIDINONE; 1,4 DIHYDRO 6 METHYL 5 N METHYL CARBAMOYL 4 (3',4' DICHLOROPHENYL) 2(3H) PYRIMIDINETHIONE; 1,4 DIHYDRO 6 METHYL 5 N METHYL CARBAMOYL 4 (4' METHOXYPHENYL) 2(3H) PYRIMIDINETHIONE; CALCIUM CHANNEL BLOCKING AGENT; PYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL INTERACTION; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; CRYSTALLIZATION; CRYSTALLOGRAPHY; MEASUREMENT; POLARIZATION; SOLID STATE; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

EID: 0041808755     PISSN: 00442968     EISSN: None     Source Type: Journal    
DOI: 10.1524/zkri.218.1.46.20771     Document Type: Article

References (38)

1. Hirakawa, S.; Ito, H.; Kondo, Y.; Watanabe, I.; Hiei, K.; Banno, S.; Hayase, S.: Coronary circulation, systemic resistance and capacitance blood vessels of dogs as effected by BAY a 1040. Arzneim.-Forsch. 22 (1972) 344-349.
2. Nayler, W. G.: In calcium antagonists. New York. Academic Press 1988.
3. Atwal, K. S.; Rovnyak, G. C.; Schwartz, J.; Moreland, S.; Hedberg, A.; Gougoutas, J. Z.; Malley, M. F.; Floyd, D. M.: Dihydropyrimidine calcium channel blockers. 2-Heterosubstituted 4-Aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of Dihydropyridines. J. Med. Chem. 33 (1990) 1510-1515.
4. Atwal, K. S., Rovnyak, G. C.; Kimball, S. D.; Floyd, D. M.; Moreland, S.; Swanson, B. N.; Gougoutas, J. Z.; Schwartz, J.; Smillie, K. M.; Malley, M. F.: Dihydropyrimidine calcium channel blockers. 3-substituted-4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimicks of dihydropyridines. J. Med. Chem. 33 (1990) 2629-2635.
5. Rovnyak, G. C.; Atwal, K. S.; Hedberg, A.; Kimball, S. D.; Moreland, S.; Gougoutas, J. Z.; O'Reilly, B. C.; Schwartz, J.; Malley, M. F.: Dihydropyrimidine calcium channel blockers. Basic 3-substituted-4-aryl-1,4-dihydropyrimidine-5-carboxylic acid esters. Potent antihypertensive agents. J. Med. Chem. 32 (1992) 3254-3263.
6. Kappe, C. O.: Biologically active dihydropyrimidones of the Biginelli-type - a literature survey. Eur. J. Med. Chem. 33 (2000) 1043-1052.
7. Kappe, C. O.; Fabian, W. M. F.; Semones, M. A.: Conformational analysis of 4-Aryl-Dihydropyrimidine calcium channel modulators. A comparison of Ab Initio, semiempirical and X-ray Crystallographic studies. Tetrahedron 53 (1997) 2803-2816.
8. Atwal, K. S.; Swanson, B. N.; Unger, S. E.; Floyd, D. M.; Moreland, S.; Hedberg, A.; O'Reilly, B. C.: Dihydropyrimidine calcium channel blockers. 3-carbamoyl-4-aryl-1,2,3,4-tetrahydro-6-methyl-5-pyrimidine carboxylic acid esters as orally effective antihypertensive agents. J. Med. Chem. 34 (1991) 806-811.
9. Hull, R.; Swain, G.: British patent (1961) 868,030.
10. Hurst, E. W.; Hull, R.: Two new synthetic substances active against viruses of Psittacosis-Lymphogranuloma - Trachoma Group. J. Med. Pharma. Chem. 3 (1961) 215-229.
11. Khanina, E. L.; Siliniece, G.; Ozols, J.; Duburs, G.; Kimenis, A.: Synthesis and pharmacological studies of some 1,2,3,4-tetrahydropyrimidine-5-carboxylic acid derivatives. Khim-Farm. Zh. 12 (1978) 72-74.
12. Triggle, D. J.; Langs, D. A.; Janis, R. A.: Ca2+ channel ligands. Structure-Function relationship of the 1,4-dihydropyridines. Med. Res. Rev. 9 (1989) 123-180.
13. Rovnyak, G. C.; Kimball, S. D.; Beyer, B.; Cucinotta, G.; DiMarco, J. D.; Gougoutas, J.; Hedberg, A.; Malley, M.; McCarthy, J. P.; Zhang, R.; Moreland, S.: Calcium entry blockers and activators: conformational and structural determinants of dihydropyrimidine calcium channel modulators. J. Med. Chem. 38 (1995) 119-129.
14. Sadanandam, Y. S.; Shetty, M. M.; Diwan, P. V.: Synthesis and biological evaluation of new 3,4-dihydro-6-methyl-5-N-methyl-carbamoyl-4-(substituted phenyl)-2(1H)pyrimidinones and pyrimidinothiones. Eur. J. Med. Chem. 27 (1992) 87-92.
15. Sheldrick, G. M.: SHELXTL-Plus. Revision 4.11N. Siemens Analytical X-ray Instruments, Inc. Application Laboratory, Single crystal, Siemens AG, AUT v353, Karlsruhe, Germany 1990.
16. Nardelli, M.: PARST. A system of FORTRAN Routines for calculating Molecular structure parameters from results of crystal structure analysis. Comput. Chem. 7 (1983) 95-98.
17. 2.7] trideca-2,4,6-triene-13-carboxylate. Acta Cryst. C52 (1996) 1496-1499.
18. 2.7] trideca-2,4,6-triene-13-carboxylate. Acta Cryst. C53 (1997) 1493-1495.
19. 5S. Acta Cryst. B30 (1974) 1550-1955.
20. 2. Acta Cryst. B32 (1976) 1090-1095.
21. 2OS. Acta Cryst. B32 (1976) 1099-1102.
22. 2O. Acta Cryst. C41 (1985) 758-760.
23. Read, G.; Randal, R.; Hursthouse, M. B.; Short, R.: Structure and properties of the thiobarbituric acid- Malonaldehyde chromogen. J. Chem. Soc. Perkin Trans. II (1988) 1103-1105.
24. Sulmon, P.; De Kimpe, N.; Schamp, N.; Declereq, J. P.: Synthesis of perhydro-1,3-diazine-2-thiones from β-chloroimines. J. Org. Chem. 54 (1988) 2587-2590.
25. Tiekink, E. R. T.: Crystal structure of 2-thiouracil. Z. Kristallogr. 187 (1989) 79-84.
26. Duax, W. L.; Norton, D. A.: Atlas of steroid structure, II New York: Plenum 1975.
27. Triggle, A. M.; Shefter, E.; Triggle, D. J.: Crystal structures of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-[2-nitro-, 3-cyano-, 4-(dimethylamino)-, and 2,3,4,5,6-pentafluorophenyl]-1,4-dihydropyridine. J. Med. Chem. 23 (1980) 1442-1445.
28. Fossheim, R.; Svarteng, K.; Mostad, A.; Romming, C.; Shefter, E.; Triggle, D. J.: Crystal structures and pharmacological activity of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-(unsubstituted, 3-methyl-, 4-methyl-, 3-nitro-, 4-nitro-, and 2,4-dinitrophenyl)-1,4-dihydropyridine. J. Med. Chem. 25 (1982) 126-131.
29. Bidya Sagar, M.; Ravikumar, K.; Sadanandam, Y. S.: Crystal structure analysis of 4-R-phenyl-2,6-dimethyl-3,5-N-(dimethyl-carbamoyl)-1,4-dihydropyridines [R=2-nitro (1), 4-methoxy (2) and 3,4-dichloro (3)]. Z. Kristallogr. 213 (1998) 182-190.
30. Linden, A.; Simsek, R.; Safak, C.: Recemic ethyl 4-(2-fluorophenyl)-2,6,6-trimethyl-5-oxo-1,4-5,6,7,8-hexahydroquinoline-3 -carboxylate. Acta Cryst. C54 (1998) 879-882.
31. 6S. Acta Cryst. C39 (1983) 1693-1695.
32. Domiano, P.; Nardelli, M.; Balsamo, A.; Macchia, B.; Macchia, F.: Crystal and molecular structure of p-methoxy benzyl 2α-methyl-2β-[(R)-acetoxy (methoxy) methyl]-6β -phenoxyacetamidopenam-3α-carboxylate. Acta Cryst. B35 (1979) 1363-1372.
33. Joseph, P. S.; Selladurai, S.; Kannan, S.; Parthasarathy, V.: 2-Amino-4-methyl-5-phenylthiophene-3-carboxamide. Acta Cryst. C47 (1991) 674-676.
34. 2+ antagonist. J. Chem. Cryst. 29 (1999) 481-491.
35. Bidya Sagar, M.; Ravikumar, K.; Mehdi, S.; Sadanandam Y. S.: Crystal and molecular structure of 2,6-dimethyl-3,5-di[N-methyl]-carbamoyl-4-[3,4-methoxy]phenyl-1, 4-dihyfropyridine hemihydrate and 2,6-dimethyl-3,5-di[N-methyl]-carbamoyl-4-[furan]-1,4-dihyfropyridine. Z. Kristallogr. 214 (1999) 850-856.
36. Atwal, K. S.; Moreland, S.: Dihydropyrimidine calcium channel blockers. 5. Bicyclic dihydropyrimidines as potent mimics of dihydropyridines. Bioorg. Med. Chem. Lett. 1 (1991) 291-294.
37. Kappe, C. O. Shishkin, O. V.; Uray, G.; Verdino, P.: X-ray structure, conformational analysis, Enantioseparation, and determination of absolute configuration of the Mitotic Kinesin. Eg5 Inhibitor Monastrol. Tetrahedron 56 (2000) 1859-1862.
38. Chandra Mohan, K.; Ravikumar, K.; Meera M. Shetty,; Thiyagarajan, S.; Rajan, S. S.: Crystal and molecular structures of 1,4-dihydro-6-methyl-5-N,N-diethylcarbamoyl-4-phenyl-2-(3 H)pyrimidinethione and 1,4-dihydro-6-methyl-5,N-methylcarbamoyl-4-(2′-nitrophenyl)-2(3 H)-pyrimidinethione hemihydrate. J. Chem. Crystallogr. Accepted.